Odonate Therapeutics, Inc. Common Stock
ODT was delisted on the 14th of January, 2022.
89 hedge funds and large institutions have $495M invested in Odonate Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 16 reducing their positions, and 29 closing their positions.
156% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 16
118% more call options, than puts
Call options by funds: $4M | Put options by funds: $1.83M
6% less funds holding
Funds holding: 95 → 89 (-6)
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
62% less capital invested
Capital invested by funds: $1.29B → $495M (-$800M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$72.4M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$52.2M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$33M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$27.6M |
| 5 |
RI
RTW Investments
New York
|
+$14.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$29.6M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$17.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.1M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$14.7M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$10.6M |
ODT Hedge Fund Activity: Q3 2020 in Review
89 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Odonate Therapeutics, Inc. Common Stock (ODT) for Q3 2020, worth a combined $495M — down 62% from $1.29B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ODT and 23 opened new positions — a net loss of 6 holders — while 16 trimmed existing stakes and 41 added.
The largest buyer was Wellington Management Group, adding an estimated $72.4M. The largest seller was Franklin Resources, cutting an estimated $29.6M.
- 89 institutional investors held Odonate Therapeutics, Inc. Common Stock (ODT) as of Q3 2020, down from 95 in Q2 2020.
- Funds reported $495M of Odonate Therapeutics, Inc. Common Stock stock for Q3 2020, down 62% quarter-over-quarter.
- 23 funds opened new Odonate Therapeutics, Inc. Common Stock positions in Q3 2020 and 29 closed out, a net change of -6 holders.
- The largest Odonate Therapeutics, Inc. Common Stock buyer in Q3 2020 was Wellington Management Group, an estimated $72.4M added.
- The largest Odonate Therapeutics, Inc. Common Stock seller in Q3 2020 was Franklin Resources, an estimated $29.6M sold.
Based on aggregated 13F filings for Q3 2020.